The Tyrosine Kinase Inhibitor Dasatinib impedes adaptive cell surveillance in peripheral lymph nodes

被引：0
|
作者：
Carvoeiro, Daniela Claudino [1 ]
Marcos-Jimenez, Ana [2 ]
Munoz-Calleja, Cecilia [2 ,3 ]
Stein, Jens Volker [1 ]
机构：
[1] Univ Fribourg, Dept Oncol Microbiol & Immunol, Fribourg, Switzerland
[2] La Princesa Hosp IIS IP, Biomed Res Inst, Dept Immunol, Madrid, Spain
[3] Inst Salud Carlos III, CIBER Infect Dis CIBERINFECC, Madrid, Spain
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
1435 - P2.
引用
收藏
页码：1099 / 1099
页数：1
相关论文
共 50 条
  • [31] Homeostatic regulatory T cell trafficking in peripheral lymph nodes
    Tong, Alexander
    Allen, Frederick
    Huang, Alex
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [32] Dasatinib, a selective tyrosine kinase inhibitor, prevents joint destruction in rheumatoid arthritis animal model
    Min, Hong Ki
    Kim, Se Hee
    Won, Ji-Yeon
    Kim, Kyoung-Woon
    Lee, Ji-Yeon
    Lee, Sang-Heon
    Kim, Hae-Rim
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (04) : 718 - 726
  • [33] Induction of apoptotic cell death by tyrosine kinase inhibitor
    Imoto, M
    Simizu, S
    Umezawa, K
    NIPPON NOGEIKAGAKU KAISHI-JOURNAL OF THE JAPAN SOCIETY FOR BIOSCIENCE BIOTECHNOLOGY AND AGROCHEMISTRY, 1997, 71 (05): : 523 - 526
  • [34] Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
    Alex J Eustace
    John Crown
    Martin Clynes
    Norma O'Donovan
    Journal of Translational Medicine, 6
  • [35] The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
    Yue Gu
    Elisa Avolio
    Valeria V Alvino
    Anita C Thomas
    Andrew Herman
    Poppy J Miller
    Niall Sullivan
    Ashton Faulkner
    Paolo Madeddu
    Cardiovascular Diabetology, 22
  • [36] The second generation tyrosine kinase inhibitor dasatinib induced eryptosis in human erythrocytes-An in vitro study
    Chan, Wai Yin
    Lau, Pui Man
    Yeung, Ka Wing
    Kong, Siu Kai
    TOXICOLOGY LETTERS, 2018, 295 : 10 - 21
  • [37] The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice
    Gu, Yue
    Avolio, Elisa
    Alvino, Valeria V.
    Thomas, Anita C.
    Herman, Andrew
    Miller, Poppy J.
    Sullivan, Niall
    Faulkner, Ashton
    Madeddu, Paolo
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [38] Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
    Hennigs, Jan K.
    Keller, Gunhild
    Baumann, Hans Joerg
    Honecker, Friedemann
    Kluge, Stefan
    Bokemeyer, Carsten
    Bruemmendorf, Tim H.
    Klose, Hans
    BMC PULMONARY MEDICINE, 2011, 11
  • [39] Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
    Jan K Hennigs
    Gunhild Keller
    Hans Jörg Baumann
    Friedemann Honecker
    Stefan Kluge
    Carsten Bokemeyer
    Tim H Brümmendorf
    Hans Klose
    BMC Pulmonary Medicine, 11
  • [40] Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
    Eustace, Alex J.
    Crown, John
    Clynes, Martin
    O'Donovan, Norma
    JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
12345